Agreement - February 18, 2015
Astra to Pay $7.9M U.S. Fine
AstraZeneca has agreed to pay American authorities $7.9 million to settle allegations the company engaged in a kickback scheme with Medco Health Solutions, a pharmacy benefit managers, to boost sales of its heartburn medication Nexium, according to a BioSpace article. “AstraZeneca embarked on this course of unlawful conduct knowing it would lead to the submission […]
Acquisition - February 18, 2015
Cerner Acquires Siemens Health Services
Cerner Corp. has completed its acquisition of Siemens Health Services’ assets, client relationships and associates. Each organization expects to invest up to $50 million during an initial three-year term. The early focus of the alliance is on integrating diagnostics and therapeutics into the electronic health record. Cerner and the former Siemens business unit have a […]
Acquisition - February 18, 2015
AstraZeneca to Acquire Actavis’ Branded Respiratory Side in U.S., Canada
AstraZeneca plans to acquire the rights to Actavis’ branded respiratory business in the U.S. and Canada for an initial consideration of $600 million on completion and low single-digit royalties above a certain revenue threshold. When the transaction is finalized, AstraZeneca will own the development and commercial rights in the US and Canada to TudorzaTM PressairTM […]
Companies - February 18, 2015
AZ Shareholders to Nominate Non-Executive Director
Cornelia Bargmann will be nominated by AstraZeneca shareholders as a non-executive director at the company’s annual general meeting on April 24. The Board of Directors is also proposing the appointment of Bargmann to AstraZeneca’s Science Committee. John Varley, senior independent non-executive director, and Nancy Rothwell, non-executive director, both intend to retire from the Board of […]
Uncategorized - February 18, 2015
Research Could Lead to Targeted Cancer Treatment
Swedish medical researchers have discovered a method for distinguishing between the most serious pediatric cancer cases and those that are less aggressive. About 20 percent of Swedish and Norwegian children diagnosed with cancer die of the disease. Oncologists have found it difficult to predict which children will improve and which will suffer a recurrence after treatment. The researchers from Sweden’s Lund […]
Uncategorized - February 16, 2015
New Interest in “Brain” Drugs
A resurgence in research into drugs for psychiatric and neurological conditions could be coming soon, as the demand for treatments for diseases such as Alzheimers, ALS, Parkinson’s and psychiatric disorders continues to rise and increased scientific knowledge is paving the way for more effective drugs. Investors last year contributed $3.3 billion to firms working on drugs for neurological or psychiatric illnesses, more […]
